Since its founding in 2016 by Dr. Jorge Méndez and his colleague Karen Obmances, VRG has been developed to offer a quality service to its sponsors and patients. The fast growth of VILO has allowed us become in a respectable company aimed to successfully be inserted as an useful choice in the new drug development industry.

Our main objective is to give minorities access to new drugs in development. Also, VRG is intended to provide our patients and researchers the opportunity to be part of clinical studies and generating the necessary data with the best possible representativity of all human groups that will receive these treatments.

We guarantee our services and the quality of our work thus we can exceed sponsors expectations. Our Commitment to every sponsor or patient is to offer accessible and accurate services. We are confident in the achievement of our goals due to our staff, with the highest qualifications and experience in conducting clinical studies.

Combining the use of independent research sites with streamlined business operations, VRG provides sponsors, CROs, and other trial industry entities with premium services leading to a fast study site identification, clinical study placement, site initiation, and successful enrollment.